Outcomes for Physiologic Microsurgical Treatment of Secondary Lymphedema Involving the Extremity
The aim of this study was to examine the long-term impact of physiologic surgical options, including VLNT and LVB, on patients with secondary lymphedema of the upper or lower extremity (UEL/LEL). VLNT and LVB have become increasingly popular in the treatment of lymphedema. However, there is a paucit...
Uloženo v:
| Vydáno v: | Annals of surgery Ročník 276; číslo 4; s. e255 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
01.10.2022
|
| Témata: | |
| ISSN: | 1528-1140, 1528-1140 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The aim of this study was to examine the long-term impact of physiologic surgical options, including VLNT and LVB, on patients with secondary lymphedema of the upper or lower extremity (UEL/LEL).
VLNT and LVB have become increasingly popular in the treatment of lymphedema. However, there is a paucity of long-term data on patient outcomes after use of these techniques to treat lymphedema.
An analysis of prospectively collected data on all patients who underwent physiologic surgical treatment of secondary lymphedema over a 5.5-year period was performed. Patient demographics, surgical details, subjective reported improvements, LLIS scores, and postoperative limb volume calculations were analyzed.
Two hundred seventy-four patients with secondary lymphedema (197 upper, 77 lower) were included in the study. More than 87% of UEL patients and 60% of LEL patients had reduction in excess limb volume postoperatively. At 3 months postoperatively, patients with UEL had a 31.1% reduction in volume difference between limbs, 33.9% at 6 months, 25.7% at 12 months, 47.4% at 24 months and 47.7% at 4 years. The reduction in limb volume difference followed a similar pattern but was overall lower for LEL patients. Greater than 86% of UEL and 75% of LEL patients also had improvement in LLIS scores postoperatively. Fifty-nine complications occurred (12.9%); flap survival was >99%.
Patients with secondary UEL/LEL who undergo VLNT/LVB demonstrate improved functional status and reduced affected limb volumes postoperatively. Patients with UEL seem to have a more substantial reduction in limb volume differential compared to LEL patients. |
|---|---|
| AbstractList | The aim of this study was to examine the long-term impact of physiologic surgical options, including VLNT and LVB, on patients with secondary lymphedema of the upper or lower extremity (UEL/LEL).OBJECTIVEThe aim of this study was to examine the long-term impact of physiologic surgical options, including VLNT and LVB, on patients with secondary lymphedema of the upper or lower extremity (UEL/LEL).VLNT and LVB have become increasingly popular in the treatment of lymphedema. However, there is a paucity of long-term data on patient outcomes after use of these techniques to treat lymphedema.SUMMARY BACKGROUND DATAVLNT and LVB have become increasingly popular in the treatment of lymphedema. However, there is a paucity of long-term data on patient outcomes after use of these techniques to treat lymphedema.An analysis of prospectively collected data on all patients who underwent physiologic surgical treatment of secondary lymphedema over a 5.5-year period was performed. Patient demographics, surgical details, subjective reported improvements, LLIS scores, and postoperative limb volume calculations were analyzed.METHODSAn analysis of prospectively collected data on all patients who underwent physiologic surgical treatment of secondary lymphedema over a 5.5-year period was performed. Patient demographics, surgical details, subjective reported improvements, LLIS scores, and postoperative limb volume calculations were analyzed.Two hundred seventy-four patients with secondary lymphedema (197 upper, 77 lower) were included in the study. More than 87% of UEL patients and 60% of LEL patients had reduction in excess limb volume postoperatively. At 3 months postoperatively, patients with UEL had a 31.1% reduction in volume difference between limbs, 33.9% at 6 months, 25.7% at 12 months, 47.4% at 24 months and 47.7% at 4 years. The reduction in limb volume difference followed a similar pattern but was overall lower for LEL patients. Greater than 86% of UEL and 75% of LEL patients also had improvement in LLIS scores postoperatively. Fifty-nine complications occurred (12.9%); flap survival was >99%.RESULTSTwo hundred seventy-four patients with secondary lymphedema (197 upper, 77 lower) were included in the study. More than 87% of UEL patients and 60% of LEL patients had reduction in excess limb volume postoperatively. At 3 months postoperatively, patients with UEL had a 31.1% reduction in volume difference between limbs, 33.9% at 6 months, 25.7% at 12 months, 47.4% at 24 months and 47.7% at 4 years. The reduction in limb volume difference followed a similar pattern but was overall lower for LEL patients. Greater than 86% of UEL and 75% of LEL patients also had improvement in LLIS scores postoperatively. Fifty-nine complications occurred (12.9%); flap survival was >99%.Patients with secondary UEL/LEL who undergo VLNT/LVB demonstrate improved functional status and reduced affected limb volumes postoperatively. Patients with UEL seem to have a more substantial reduction in limb volume differential compared to LEL patients.CONCLUSIONSPatients with secondary UEL/LEL who undergo VLNT/LVB demonstrate improved functional status and reduced affected limb volumes postoperatively. Patients with UEL seem to have a more substantial reduction in limb volume differential compared to LEL patients. The aim of this study was to examine the long-term impact of physiologic surgical options, including VLNT and LVB, on patients with secondary lymphedema of the upper or lower extremity (UEL/LEL). VLNT and LVB have become increasingly popular in the treatment of lymphedema. However, there is a paucity of long-term data on patient outcomes after use of these techniques to treat lymphedema. An analysis of prospectively collected data on all patients who underwent physiologic surgical treatment of secondary lymphedema over a 5.5-year period was performed. Patient demographics, surgical details, subjective reported improvements, LLIS scores, and postoperative limb volume calculations were analyzed. Two hundred seventy-four patients with secondary lymphedema (197 upper, 77 lower) were included in the study. More than 87% of UEL patients and 60% of LEL patients had reduction in excess limb volume postoperatively. At 3 months postoperatively, patients with UEL had a 31.1% reduction in volume difference between limbs, 33.9% at 6 months, 25.7% at 12 months, 47.4% at 24 months and 47.7% at 4 years. The reduction in limb volume difference followed a similar pattern but was overall lower for LEL patients. Greater than 86% of UEL and 75% of LEL patients also had improvement in LLIS scores postoperatively. Fifty-nine complications occurred (12.9%); flap survival was >99%. Patients with secondary UEL/LEL who undergo VLNT/LVB demonstrate improved functional status and reduced affected limb volumes postoperatively. Patients with UEL seem to have a more substantial reduction in limb volume differential compared to LEL patients. |
| Author | Agarwal, Shailesh Beederman, Maureen Garza, Rebecca M Chang, David W |
| Author_xml | – sequence: 1 givenname: Maureen surname: Beederman fullname: Beederman, Maureen organization: Section of Plastic and Reconstructive Surgery, Department of Surgery, The University of Chicago, Chicago, Illinois – sequence: 2 givenname: Rebecca M surname: Garza fullname: Garza, Rebecca M – sequence: 3 givenname: Shailesh surname: Agarwal fullname: Agarwal, Shailesh – sequence: 4 givenname: David W surname: Chang fullname: Chang, David W |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32889875$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNUF9LwzAcDDJxf_QbiOTRl84kTZv0cYypg8qEzeeaJr9ulaaZTTvst7fghN3L3cFxcDdFo9rVgNA9JXNKEvG0TRdzcgHOI3GFJjRiMqCUk9GFHqOp91-EUC6JuEHjkEmZSBFN0Oema7Wz4HHhGvx-6H3pKrcvNX4rdeN81wxaVXjXgGot1C12Bd6CdrVRTY_T3h4PYMAqvK5PrjqV9R63B8Crn7YBW7b9LbouVOXh7swz9PG82i1fg3Tzsl4u0kAzyeKAycQIlpNwsEbSWBIQeaxDliujFBMR0WFilIwjapQoQCdCFpoXPCmAKKHZDD3-9R4b992BbzNbeg1VpWpwnc8Y54THyTB7iD6co11uwWTHprTDmOz_FfYLdP5ogw |
| CitedBy_id | crossref_primary_10_1097_PRS_0000000000010591 crossref_primary_10_1245_s10434_020_09348_y crossref_primary_10_1245_s10434_021_09920_0 crossref_primary_10_3390_cancers13143584 crossref_primary_10_3390_lymphatics1020013 crossref_primary_10_3390_medicina61081327 crossref_primary_10_1089_lrb_2020_0098 crossref_primary_10_1097_PRS_0000000000011675 crossref_primary_10_1097_SLA_0000000000005591 crossref_primary_10_1007_s11547_021_01410_3 crossref_primary_10_1097_JS9_0000000000000210 crossref_primary_10_1097_SLA_0000000000006860 crossref_primary_10_1016_j_jvsv_2023_08_015 crossref_primary_10_3390_cancers13071540 crossref_primary_10_1097_PRS_0000000000010965 crossref_primary_10_1016_j_jfma_2024_01_010 crossref_primary_10_1097_PRS_0000000000011745 crossref_primary_10_1055_a_2257_5345 crossref_primary_10_1089_lrb_2021_0051 crossref_primary_10_3390_medicina59071194 crossref_primary_10_1002_micr_30878 crossref_primary_10_1002_micr_30844 crossref_primary_10_1016_j_bjps_2025_06_038 crossref_primary_10_1097_PRS_0000000000009761 |
| ContentType | Journal Article |
| Copyright | Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1097/SLA.0000000000004457 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 1528-1140 |
| ExternalDocumentID | 32889875 |
| Genre | Journal Article |
| GroupedDBID | --- .-D .XZ .Z2 01R 0R~ 1J1 23M 354 40H 4Q1 4Q2 4Q3 53G 5GY 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPPZ ABPXF ABVCZ ABXVJ ABXYN ABZAD ABZZY ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACWDW ACWRI ACXJB ACXNZ ACZKN ADGGA ADHPY AE6 AEBDS AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHJKT AHOMT AHQNM AHQVU AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AZFZN BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIWNM E.X EBS ECM EEVPB EIF ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IH2 IKREB IKYAY IN~ IPNFZ J5H JF7 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P RIG RLZ RPM RXW S4R S4S TAF TEORI TSPGW UQX V2I VVN W3M WH7 WOQ WOW X3V X3W XXN XYM YFH YOC ZFV ZY1 ~H1 7X8 ACBKD ADKSD ADSXY |
| ID | FETCH-LOGICAL-c2826-289d72b03c28d81680e7b6c32badaa2750c39da8651da7fec978fc4f49fe0a7c2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 39 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=00000658-202210000-00026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-1140 |
| IngestDate | Sun Nov 09 14:30:26 EST 2025 Mon Jul 21 05:33:52 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2826-289d72b03c28d81680e7b6c32badaa2750c39da8651da7fec978fc4f49fe0a7c2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 32889875 |
| PQID | 2440469898 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2440469898 pubmed_primary_32889875 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-10-01 20221001 |
| PublicationDateYYYYMMDD | 2022-10-01 |
| PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Annals of surgery |
| PublicationTitleAlternate | Ann Surg |
| PublicationYear | 2022 |
| SSID | ssj0014807 |
| Score | 2.5564106 |
| Snippet | The aim of this study was to examine the long-term impact of physiologic surgical options, including VLNT and LVB, on patients with secondary lymphedema of the... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | e255 |
| SubjectTerms | Humans Lower Extremity - surgery Lymph Nodes - surgery Lymphedema - etiology Lymphedema - surgery Microsurgery Surgical Flaps - surgery Upper Extremity |
| Title | Outcomes for Physiologic Microsurgical Treatment of Secondary Lymphedema Involving the Extremity |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32889875 https://www.proquest.com/docview/2440469898 |
| Volume | 276 |
| WOSCitedRecordID | wos00000658-202210000-00026&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFB7UevDiglvdGMFraJqZzGROUqRFoa2FVugtTmYBD01q0or9977JQk-CYA6BBBLCy8w331vmfQg9hFxHWliYSAlAIE2ckHtCmCeoCm0gtAiJLcUm-HgczediUgfcirqsssHEEqh1plyMvBO4Rnal2uHj8tNzqlEuu1pLaOyiFgEq40q6-HybRai3S8MSBZ4SeBLN1jnBO9Nhr2pdWB-Uhvx3klkuNoOj_37mMTqsaSbuVePiBO2Y9BS9v65X8BZTYGCquKz9rKAPj1xZXrHOSxjEs6b4HGcWT53HrGW-wcMN_HmjzULilxRQzYUiMPBH3P9e5WYBdP4MvQ36s6dnr1ZY8BS4WswDb0vzIPEJXGqnwOEbnjBFgkRqKV3rd0WElhELu1pyaxT4nFZRS4U1vuQqOEd7aZaaS4QdcEhmuoRpRruWiyS0PtOGMd8CJ6FtdN8YLIYR7NISMjXZuoi3Jmuji8rq8bJqtRGTIIL7PLz6w9PX6CBwexPKSrsb1LIwf80t2ldfq48ivyuHBpzHk9EPn_XDrg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Outcomes+for+Physiologic+Microsurgical+Treatment+of+Secondary+Lymphedema+Involving+the+Extremity&rft.jtitle=Annals+of+surgery&rft.au=Beederman%2C+Maureen&rft.au=Garza%2C+Rebecca+M&rft.au=Agarwal%2C+Shailesh&rft.au=Chang%2C+David+W&rft.date=2022-10-01&rft.issn=1528-1140&rft.eissn=1528-1140&rft.volume=276&rft.issue=4&rft.spage=e255&rft_id=info:doi/10.1097%2FSLA.0000000000004457&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-1140&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-1140&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-1140&client=summon |